Anzeige
Mehr »
Dienstag, 21.07.2026 - Börsentäglich über 12.000 News
+50% in 13 Tagen - Steht der große Ausbruch jetzt bevor?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PUQT | ISIN: DK0061155009 | Ticker-Symbol:
1-Jahres-Chart
PHARMA EQUITY GROUP A/S Chart 1 Jahr
5-Tage-Chart
PHARMA EQUITY GROUP A/S 5-Tage-Chart

Aktuelle News zur PHARMA EQUITY GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12.06.Pharma Equity Group A/S: Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs34612 June 2026 Announcement no. 8 Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs Pharma Equity Group A/S ("PEG"...
► Artikel lesen
11.05.Pharma Equity Group A/S: Pharma Equity Group's subsidiary Reponex takes key step forward in Inflammatory Bowel Disease with upcoming European patent grant132Pharma Equity Group's subsidiary Reponex takes key step forward in Inflammatory Bowel Disease with upcoming European patent grant May 11, 2026Announcement no. 7 Pharma Equity Group A/S today announces...
► Artikel lesen
28.04.Pharma Equity Group A/S: The Board of Directors' resolution on the issuance of convertible loans1
17.04.Proceedings of the Annual General Meeting of Pharma Equity Group A/S171Proceedings of the Annual General Meeting of Pharma Equity Group A/S 17 April 2026Company Announcement no. 5 Pharma Equity Group A/S held its annual general meeting on 16 April 2026 at 3:30 pm CEST...
► Artikel lesen
25.03.Notice convening the annual general meeting in Pharma Equity Group A/S1
PHARMA EQUITY GROUP Aktie jetzt für 0€ handeln
25.03.Pharma Equity Group A/S - Annual Report 202517825 March 2026 Announcement no. 3 Pharma Equity Group A/S - Annual Report 2025 Pharma Equity Group A/S - Annual Report 2025 - Highlights of the year Today, the Board of Directors of Pharma Equity Group...
► Artikel lesen
26.02.Pharma Equity Group A/S: SUPPLEMENTARY INFORMATION (CORRECTIVE INFORMATION) TO THE ANNUAL REPORT 2024 AND THE INTERIM REPORT FOR H1 20252
03.02.Pharma Equity Group A/S: 2026 Financial Calendar1
29.12.25Pharma Equity Group A/S: Pharma Equity Group - Strategic update and adjustment of expectations304Pharma Equity Group - Strategic update and adjustment of expectations Copenhagen, 29 December 2025 Company Announcement no. 16 Pharma Equity Group A/S ("PEG" or the "Company") hereby provides a strategic...
► Artikel lesen
10.12.25Pharma Equity Group A/S: Pharma Equity Group executes on the Company's new strategy: Enters into Letter of Intent to acquire the MedTech company Otiom A/S195Pharma Equity Group executes on the Company's new strategy: Enters into Letter of Intent to acquire the MedTech company Otiom A/S Copenhagen, 10 December 2025 Company Announcement no. 15 Pharma Equity...
► Artikel lesen
03.12.25Pharma Equity Group A/S' agreement with Danske Bank as liquidity provider will terminate on 1 January 2026310Pharma Equity Group A/S' agreement with Danske Bank as liquidity provider will terminate on 1 January 2026 3 December 2025 Company Announcement no. 14 Pharma Equity Group A/S ("PEG") announces that...
► Artikel lesen
01.09.25Pharma Equity Group A/S: Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis418Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis Copenhagen, September...
► Artikel lesen
14.08.25Pharma Equity Group A/S: Consolidated Interim Report 1 January - 30 June 2025229Consolidated Interim Report 1 January - 30 June 2025Key points from the H1-2025 report (period 1 January - 30 June 2025) 14 August 2025Announcement no. 9 On 14 August 2025, the Board of Directors...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1